Market Research Logo

Point of Care Diagnostics

Point of Care Diagnostics

The global point of care (POC) diagnostics market was valued at nearly $16.8 billion and $18.0 billion in 2014 and 2015, respectively. This market is expected to grow from $19.3 billion in 2016 to $28.3 billion in 2021 at a compound annual growth rate (CAGR) of 8.0% for 2016-2021.

This report provides:
An overview of the global markets for point of care diagnostics.
Analyses of global market trends, with data from 2014 and 2015, estimates for 2016, and projections of compound annual growth rates (CAGRs) through 2021.
Discussion of factors driving the market including staff shortages, older populations, long-term cost savings, and need for faster diagnosis and care.
A look at how availability of POC testing has revolutionized the continuum of the patient-care process.
In depth analysis of the major force driving the growth of this industry, the effort to provide better patient care by improving the turn-around-time (TAT) that POC testing offers.
A look at the other market factors including growth restraints and opportunities.
Profiles of major players in the industry.


SCOPE OF REPORT

This study will describe the market for POC diagnostics at the global level. It focuses on the accelerating growth in this important diagnostic market segment and the key industry players. Specifically, the report:

Describes the POC industry. 
Estimates the current and future market size.
Provides breakdowns for U.S. markets.
Describes product segments and the continuous updating of POC products.
Analyzes market influences in the industry and predicts the changes that will shape the future POC market.
Discusses trends within the market and provides a future outlook. 
Reviews business activities of market leaders. 
Lists patents for POC technologies.

CHAPTER 1 INTRODUCTION
STUDY GOALS AND OBJECTIVES
REASONS FOR DOING THE STUDY
CONTRIBUTION OF THE STUDY AND FOR WHOM
SCOPE OF REPORT
DEFINING POC
METHODOLOGY
ANALYST'S CREDENTIALS
RELATED BCC RESEARCH REPORTS
BCC RESEARCH WEBSITE
DISCLAIMER
CHAPTER 2 SUMMARY
OVERVIEW
MAJOR FINDINGS
SUMMARY TABLE GLOBAL POC MARKET, BY REGION, THROUGH 2021 ($ MILLIONS)
SUMMARY FIGURE GLOBAL POC MARKET, BY REGION, 2014-2021 ($ MILLIONS)
CHAPTER 3 INDUSTRY OVERVIEW
WHAT IS POC TESTING?
INDUSTRY TERMS[1]
OVERVIEW OF THE POC MARKET
POC AS PART OF CLINICAL DIAGNOSTICS INDUSTRY STRUCTURE
MEDICAL BENEFITS DERIVED FROM IMMEDIATE DIAGNOSTIC TESTING
POC TESTING SITES
TABLE 1 SELECTED KEY STATISTICS FOR POC TESTING SITES HOME USE/SELF-CARE
EMERGENCY ROOMS
CRITICAL-CARE UNITS
BEDSIDE TESTING
TABLE 2 ESTIMATED NUMBER OF HOSPITALS/INPATIENT ACUTE CARE CENTERS AND BEDS AVAILABLE BY SELECTED COUNTRY, 2016
FIGURE 1 ESTIMATED NUMBER OF INPATIENT CARE FACILITIES AND AVAILABLE BEDS BY SELECTED COUNTRY, 2016
OPERATING ROOMS/PROCEDURE ROOMS
PHYSICIANS OFFICES/CLINICS/TREATMENT CENTERS/OTHER
NONCRITICAL-CARE SITES
Nursing Homes and Hospice
TABLE 3 ESTIMATED NURSING HOMES RESIDENTS BY SELECTED U.S. STATES, 2016 (NO./%)
TABLE 4 HOSPICE FACTS, 2016 ESTIMATED
POC PRODUCT SEGMENTS
POC CLINICAL ASSAY CATEGORIES
Blood Chemistry and Electrolytes
Cardiac Marker
Cholesterol Testing/Monitoring
Drug and Alcohol Screening
Glucose Testing and Monitoring
Infectious Disease Testing
Pregnancy and Fertility Testing
Hemoglobin and Hemostasis
Tumor Marker
Urinalysis/Urine Chemistry
COMMONLY PERFORMED POC TESTS
TABLE 5 SELECTED POC TESTS—CLIA WAIVED
SIGNIFICANCE OF CLIA IN THE UNITED STATES
THE FDA'S ROLE IN POC TESTING
GOOD MANUFACTURING PRACTICE
TABLE 6 PERTINENT PARAMETERS OF GMP REGULATIONS AFFECTING IN VITRO DIAGNOSTICS
DRIVING FORCES OF THE POC MARKET
COST CONTAINMENT
Rising Healthcare Costs
TABLE 7 HEALTH EXPENDITURES AS PERCENTAGE OF GDP BY SELECT COUNTRY. 1980-2015 (%)
FIGURE 2 HEALTH EXPENDITURES AS PERCENTAGE OF GDP BY SELECT COUNTRY, 1980-2015 (%)
TABLE 8 HEALTH EXPENDITURES AS PERCENTAGE OF GDP BY COUNTRY: TOP 20 SPENDERS, 2016 (%)
FIGURE 3 HEALTH EXPENDITURES AS PERCENT OF GDP BY COUNTRY: TOP 20 SPENDERS, 2016 (%)
Trends in Hospital Length of Stay
TABLE 9 HOSPITAL USAGE STATISTICS, 2005 COMPARED WITH 2015 (DAYS)
FIGURE 4 HOSPITAL USAGE STATISTICS, 2005 AND 2015 (DAYS)
PUBLIC HEALTHCARE SYSTEMS AROUND THE WORLD
TABLE 10 WORLD HEALTH ORGANIZATION RANKING OF HEALTHCARE
SYSTEMS, TOP 50, 2010
GLOBAL SHORTAGE OF HEALTHCARE WORKERS
TECHNOLOGICAL ADVANCEMENT
Availability-Ease of Use Devices
New Technologies
INCIDENCE OF DISEASE
TABLE 11 STATISTICS OF SELECTED DISEASES IN THE GLOBAL POPULATION, 2016 ESTIMATES
Asthma
Cardiovascular Disease
Cancer
Diabetes
Diarrheal Disease
HIV
Infertility
Influenza
Malaria
Pregnancy
TABLE 12 BIRTH RATES AND BIRTHS BY COUNTRY, 2016 ESTIMATES (THOUSAND/%)
FIGURE 5 BIRTH RATES AND BIRTHS BY COUNTRY, 2016 ESTIMATES (THOUSAND/%)
Tuberculosis
ATTENTION TO DRUGS OF ABUSE
DEMOGRAPHICS AND AGING POPULATIONS
Global Demographics
TABLE 13 ESTIMATED GLOBAL POPULATION AND ANNUAL GROWTH BY SELECTED AGE GROUP AND SELECTED YEARS, THROUGH 2030 (MILLIONS)
FIGURE 6 ESTIMATED GLOBAL POPULATION BY SELECTED AGE GROUP AND SELECTED YEARS, 2000-2030 (MILLIONS)
TABLE 14 GLOBAL POPULATION BY SELECTED COUNTRY, THROUGH 2015 (MILLIONS)
FIGURE 7 GLOBAL POPULATION BY SELECTED COUNTRY, 2010 AND 2015 (MILLIONS)
Global Life Expectancy
TABLE 15 GLOBAL LIFE EXPECTANCY AT BIRTH BY SELECTED COUNTRY, 1980 AND 2010 (YEARS)
FIGURE 8 GLOBAL LIFE EXPECTANCY AT BIRTH BY SELECTED COUNTRY, 1980 AND 2010 (YEARS)
U.S. Demographics
TABLE 16 U.S. POPULATION ESTIMATES AND PROJECTIONS BY AGE GROUP, 1900-2050 (THOUSANDS)
FIGURE 9 U.S. POPULATION ESTIMATES AND PROJECTIONS BY AGE GROUP, 1900 TO 2050 (THOUSANDS)
Gender, Age and Life Expectancy
TABLE 17 ESTIMATES OF EXPECTED U.S. LIFE EXPECTANCY AT
BIRTH WITH PROJECTIONS BY SEX, 1990-2020 (YEARS)
FIGURE 10 ESTIMATES OF EXPECTED U.S. LIFE EXPECTANCY AT BIRTH WITH PROJECTIONS BY SEX, 1990-2020 (YEARS)
TABLE 18 GLOBAL LIFE EXPECTANCY AT BIRTH BY SELECTED COUNTRY, 1980 AND 2015 (YEARS)
FIGURE 11 GLOBAL LIFE EXPECTANCY AT BIRTH BY SELECTED COUNTRY, 1980 AND 2015 (YEARS)
CHAPTER 4 THE GLOBAL POC MARKET
MARKET OVERVIEW
TABLE 19 GLOBAL FORECAST FOR THE POC MARKET BY TEST TYPE, THROUGH 2021 ($ MILLIONS)
FIGURE 12 GLOBAL FORECAST FOR THE POC MARKET BY TEST TYPE, 2016 AND 2021 ($ MILLIONS)
FIGURE 13 DISTRIBUTION OF SALES FOR THE GLOBAL POC MARKET BY TEST TYPE, 2016 (%)
COMPETITOR MARKET SHARE
TABLE 20 MARKET SHARE OF MAJOR POC MARKET PARTICIPANTS, 2016 (%)
FIGURE 14 MARKET SHARE OF MAJOR POC MARKET PARTICIPANTS, 2016 (%)
MARKET STRUCTURE
DISTRIBUTION
FIGURE 15 DISTRIBUTION CHANNELS: POC DIAGNOSTIC DEVICES
PROMOTION
STRATEGIC ALLIANCES AND MERGERS
MARKET COMPONENTS
BLOOD CHEMISTRY AND ELECTROLYTE TESTING
CARDIAC MARKER TESTING
CHOLESTEROL TESTING
DRUG AND ALCOHOL ABUSE TESTING
GLUCOSE TESTING
INFECTIOUS DISEASE TESTING
PREGNANCY AND FERTILITY TESTING
HEMATOLOGY AND HEMOSTASIS TESTING
TUMOR MARKER TESTING
URINE CHEMISTRY TESTING
MISCELLANEOUS POC TESTING
CHAPTER 5 BLOOD CHEMISTRY AND ELECTROLYTE TESTING
SEGMENT OVERVIEW
BLOOD CHEMISTRY PARAMETERS
ELECTROLYTES
CLIA Quality Control Requirements for Blood Gas Analysis
MARKET SIZE
MARKET PARTICIPANTS AND MARKET SHARES
TABLE 21 RELATIVE MARKET SHARE OF POC BLOOD CHEMISTRY ANALYZER MANUFACTURERS, 2016 (%)
FIGURE 16 RELATIVE MARKET OF SHARE BLOOD GAS ANALYZER MANUFACTURERS, 2016 (%)
ABBOTT DIAGNOSTICS
i-STAT
ABAXIS
Piccolo Classic and Piccolo Xpress
TABLE 22 ABAXIS PICCOLO ANALYZER TEST AVAILABILITY
ALERE
Epoc Blood Analysis System
INTERNATIONAL TECHNIDYNE CORP.
IRMA TRUpoint Blood Analysis System
AVOXimeter Whole Blood CO-Oximeter/Oximeter System
NOVA BIOMEDICAL
Stat Profile pHOx Product Line
TABLE 23 NOVA BIOCHEMICAL POC STAT PROFILE PHOX SERIES BY AVAILABLE TESTS
RADIOMETER AMERICA INC.
ABL80, ABL90 FLEX, ABL800 FLEX
ROCHE DIAGNOSTICS
Cobas b 121 System
Cobas b 221 Blood Gas System
SIEMENS HEALTHCARE
Rapidpoint 400/405
RAPIDComm Data Management System
CHAPTER 6 CARDIAC MARKER TESTING
SEGMENT OVERVIEW
MARKET SIZE
MARKET PARTICIPANTS AND MARKET SHARES
TABLE 24 RELATIVE MARKET SHARE OF POC CARDIAC MARKER MANUFACTURERS, 2016 (%)
FIGURE 17 RELATIVE MARKET SHARE OF POC CARDIAC MARKER MANUFACTURERS, 2016 (%)
ABBOTT
iSTAT 1
ALERE
Triage System
Triage BNP Test
Heart Check System
ROCHE
Cobas h 232 System
RESPONSE BIOMEDICAL
RAMP System
SIEMENS
Stratus CS Acute Care Diagnostic System
CHAPTER 7 CHOLESTEROL TESTING
SEGMENT OVERVIEW
MARKET SIZE
MARKET PARTICIPANTS AND MARKET SHARES
TABLE 25 RELATIVE MARKET SHARE OF CHOLESTEROL POC RAPID TEST MANUFACTURERS, 2016 (%)
FIGURE 18 RELATIVE MARKET SHARE OF CHOLESTEROL POC RAPID TEST MANUFACTURERS, 2016 (%)
TABLE 26 CLIA-WAIVED APPROVED CHOLESTEROL TESTS, 2015-2016
ABAXIS
ALERE
ROCHE DIAGNOSTICS
CHAPTER 8 DRUG AND ALCOHOL ABUSE TESTING
SEGMENT OVERVIEW
MARKET SIZE
MARKET PARTICIPANTS AND MARKET SHARES
TABLE 27 RELATIVE MARKET SHARE OF DRUG AND ALCOHOL POC RAPID TEST MANUFACTURERS, 2016 (%)
FIGURE 19 RELATIVE MARKET SHARE OF DRUG AND ALCOHOL POC RAPID TEST MANUFACTURERS, 2016 (%)
TABLE 28 CLIA-WAIVED APPROVED POC DRUG AND ALCOHOL SCREENING TESTS, 2015-2016
ALERE
ORASURE TECHNOLOGIES
PHAMATECH
CHAPTER 9 GLUCOSE TESTING
SEGMENT OVERVIEW
MARKET SIZE
MARKET PARTICIPANTS AND MARKET SHARES
TABLE 29 RELATIVE MARKET SHARE FOR GLUCOSE METERS AND SUPPLIES MANUFACTURERS, 2016 (%)
FIGURE 20 RELATIVE MARKET SHARE FOR GLUCOSE METERS AND SUPPLIES MANUFACTURERS, 2016 (%)
TABLE 30 CLIA-WAIVED APPROVED BLOOD GLUCOSE METERS, 2015-2016
TABLE 31 CLIA-WAIVED APPROVED BLOOD GLUCOSE METERS, 2013 AND PRIOR
ROCHE DIAGNOSTICS
Accu-Chek Nano Meter System
Accu-Chek Aviva Meter System
Accu-Chek Compact Plus Meter System
Accu-Chek Active System
Accu-Chek Inform System
Accu-Chek Inform II
Accu-Chek Voicemate System
JOHNSON AND JOHNSON
LifeScan-OneTouch Ultra 2 Meter
LifeScan-OneTouch UltraMini
LifeScan-OneTouch Verio and Verio IQ
LifeScan-OneTouch Ultra Meter
LifeScan OneTouch InDuo System
LifeScan OneTouch Basic Meter
LifeScan OneTouch SureStep Meter
LifeScan OneTouch UltraLink Meter
LifeScan OneTouch Diabetes Management Software
ABBOTT DIABETES CARE
FreeStyle Blood Glucose Monitoring System
Precision Blood Glucose and Ketone Monitoring Systems
i-STAT 1
TREVIDIA HEALTH
Sidekick Testing System
TrueTrack Smart System
SIEMENS
DCA Vantage Analyzer
Home Diagnostic Meters—Retailers
TABLE 32 SELECTED LISTING OF RETAILERS SELLING HOME
DIAGNOSTIC METERS
Data Management Systems
TABLE 33 SELECT LISTING OF BLOOD GLUCOSE MONITORS CAPABLE
OF INTERACTING WITH COMPUTER SOFTWARE
CHAPTER 10 INFECTIOUS DISEASE TESTING
SEGMENT OVERVIEW
MARKET SIZE
TABLE 34 ESTIMATED MARKET SHARE FOR THE GLOBAL POC INFECTIOUS DISEASE MARKET BY TEST TYPE, 2016 (%)
FIGURE 21 ESTIMATED MARKET SHARE FOR THE GLOBAL POC INFECTIOUS DISEASE MARKET BY TEST TYPE, 2016 (%)
MARKET PARTICIPANTS AND MARKET SHARES
TABLE 35 RELATIVE MARKET SHARE OF INFECTIOUS DISEASE POC RAPID TEST MANUFACTURERS, 2016 (%)
FIGURE 22 RELATIVE MARKET SHARE OF INFECTIOUS DISEASE POC RAPID TEST MANUFACTURERS, 2016 (%)
STREP A
INFLUENZA
CHLAMYDIA
SPECIFIC PRODUCTS FOR TESTING
Strep A
TABLE 36 CLIA-WAIVED APPROVED POC INFECTIOUS DISEASE TESTS, 2015-2016
TABLE 37 CLIA-WAIVED APPROVED STREP A TESTS, 2013 AND PRIOR
Alere Inc.
Beckman Coulter
BTNX Inc.
Quidel
Influenza
TABLE 38 CLIA-WAIVED APPROVED INFLUENZA TESTS
Alere Inc.
Becton Dickinson
OraSure Technologies
Quidel
SA Scientific
Chlamydia/Trichomoniasis
TABLE 39 CLIA-WAIVED APPROVED CHLAMYDIA/TRICHOMONAS TEST
Quidel
Sekisui Diagnostics
RSV
TABLE 40 CLIA-WAIVED APPROVED RSV TESTS
Alere
BTNX Inc.
Quidel
HIV Testing
TABLE 41 CLIA-WAIVED APPROVED HIV TESTS
Alere Inc.
OraSure Technologies
Trinity Biotech plc
Infectious Mononucleosis
TABLE 42 CLIA-WAIVED APPROVED INFECTIOUS MONONUCLEOSIS
TESTS
Beckman Coulter
Quidel
H. pylori
TABLE 43 CLIA-WAIVED APPROVED H. PYLORI TESTS
Quidel
Herpes Simplex Virus
Trinity Biotech
Syphilis Treponemal
Trinity Biotech
Hepatitis C Virus
TABLE 44 CLIA-WAIVED APPROVED HCV TESTS
S. Pneumoniae
Trinity Biotech
Adenovirus
TABLE 45 CLIA-WAIVED APPROVED ADENOVIRUS TEST
CHAPTER 11 PREGNANCY AND FERTILITY TESTING
SEGMENT OVERVIEW
MARKET SIZE
TABLE 46 MARKET SHARE FOR THE GLOBAL POC PREGNANCY/FERTILITY MARKET BY TEST TYPE, 2016 (%)
FIGURE 23 MARKET SHARE FOR THE GLOBAL POC PREGNANCY/FERTILITY MARKET BY TEST TYPE, 2016 (%)
MARKET PARTICIPANTS AND MARKET SHARES
TABLE 47 RELATIVE MARKET SHARE OF PREGNANCY/FERTILITY POC RAPID TEST MANUFACTURERS, 2016 (%)
FIGURE 24 RELATIVE MARKET SHARE OF PREGNANCY/FERTILITY POC RAPID TEST MANUFACTURERS, 2016 (%)
TABLE 48 CLIA-WAIVED APPROVED POC PREGNANCY TESTS, 2015-2016
TABLE 49 CLIA-WAIVED APPROVED PREGNANCY TESTS, 2013 AND PRIOR
CHAPTER 12 HEMOGLOBIN/HEMOSTASIS TESTING
HEMATOLOGY AND HEMOSTASIS
HEMOSTASIS (COAGULATION)
MARKET SIZE
MARKET PARTICIPANTS AND MARKET SHARES
TABLE 50 RELATIVE MARKET SHARE OF HEMOGLOBIN/HEMOSTASIS POC RAPID TEST MANUFACTURERS, 2016 (%)
FIGURE 25 RELATIVE MARKET SHARE OF HEMOGLOBIN/HEMOSTASIS POC RAPID TEST MANUFACTURERS, 2016 (%)
TABLE 51 CLIA-WAIVED APPROVED POC HEMATOLOGY TESTS, 2015-2016
TABLE 52 CLIA-WAIVED APPROVED HEMATOLOGY TESTS, 2013 AND PRIOR
ALERE
ROCHE
CHAPTER 13 TUMOR MARKER TESTING
SEGMENT OVERVIEW
FECAL AND GASTRIC OCCULT BLOOD
BLADDER TUMOR ANTIGEN TEST
MARKET SIZE
MARKET PARTICIPANTS AND MARKET SHARES
TABLE 53 RELATIVE MARKET SHARE OF TUMOR MARKER POC RAPID TEST MANUFACTURERS, 2016 (%)
FIGURE 26 RELATIVE MARKET SHARE OF TUMOR MARKER POC RAPID TEST MANUFACTURERS, 2016 (%)
TABLE 54 CLIA-WAIVED APPROVED POC FECAL OCCULT BLOOD TESTS, 2015-2016
TABLE 55 CLIA-WAIVED APPROVED FECAL OCCULT BLOOD TESTS, 2013 AND PRIOR
BECKMAN COULTER
QUIDEL
TABLE 56 CLIA-WAIVED APPROVED BLADDER TESTS
ALERE
CHAPTER 14 URINE CHEMISTRY TESTING
SEGMENT OVERVIEW
MARKET SIZE
MARKET PARTICIPANTS AND MARKET SHARES
TABLE 57 RELATIVE MARKET SHARE OF POC URINE CHEMISTRY ANALYZER MANUFACTURERS, 2016 (%)
FIGURE 27 RELATIVE MARKET SHARE OF POC URINE CHEMISTRY ANALYZER MANUFACTURERS, 2016 (%)
TABLE 58 CLIA-WAIVED APPROVED POC URINE CHEMISTRY TESTS AND ANALYZERS TESTS, 2015-2016
TABLE 59 CLIA-WAIVED APPROVED URINE CHEMISTRY TESTS AND ANALYZERS, 2013 AND PRIOR
SIEMENS
CHAPTER 15 OTHER POC TESTING
MARKET SIZE
SEGMENT OVERVIEW
VAGINAL PH TESTS
TABLE 60 CLIA-WAIVED APPROVED VAGINAL PH TEST
THYROID STIMULATING HORMONE TESTS
TABLE 61 CLIA-WAIVED APPROVED TSH TESTS
MALE REPRODUCTIVE TESTS
TABLE 62 CLIA-WAIVED APPROVED MALE REPRODUCTIVE TEST
MENOPAUSE
TABLE 63 CLIA-WAIVED APPROVED MENOPAUSE TEST
DRY EYE
TABLE 64 CLIA-WAIVED APPROVED DRY EYE TEST
CHAPTER 16 TECHNOLOGY APPLICATIONS
INTRODUCTION
ELECTRONIC DATA MANAGEMENT INTEGRATION
POC DEVICE CASE STUDIES-SIEMENS HEALTHCARE
ABBOTT I-STAT AND HEALTH RECORDS
BIOSENSORS
WHAT ARE BIOSENSORS?
Catalytic Sensors
Affinity Sensors
ELECTRODES
WHAT ARE ELECTRODES?
CONTINUOUS TESTING
OCCLUSION SPECTROSCOPY
TRANSDERMAL ALCOHOL CONTINUOUS TESTING
NONINVASIVE ELECTRONIC SKIN SENSORS
RAPID HIV TESTS
CHEMBIO DIAGNOSTIC SYSTEMS INC.
RAPID CLINICAL DRUG TESTING
PSYCHEMEDICS CORP.
TEARLAB CORP'S OSMOLARITY SYSTEM
PATENT ANALYSIS
NUMBER OF RECENTLY ISSUED PATENTS
TABLE 65 SELECTED U.S. PATENTS FOR POC DIAGNOSTIC TESTING, JANUARY 2014 TO JULY 2016
Glucose
TABLE 66 U.S. PATENTS FOR POC DIAGNOSTIC GLUCOSE TESTING, JANUARY 2014 TO JULY 2016
Blood chemistry and Electrolyte
Pregnancy and Fertility
TABLE 67 U.S. PATENT FOR POC DIAGNOSTIC PREGNANCY TESTING, JANUARY 2014 TO JULY 2016
Infectious Disease
TABLE 68 U.S. PATENTS FOR POC DIAGNOSTIC INFECTIOUS DISEASE TESTING, JANUARY 2014 TO JULY 2016
Cholesterol
TABLE 69 U.S. PATENT FOR POC DIAGNOSTIC CHOLESTEROL TESTING, JANUARY 2014 TO JULY 2016
Urine
TABLE 70 U.S. PATENTS FOR POC DIAGNOSTIC URINE TESTING, JANUARY 2014 TO JULY 2016
SELECTED PATENT ASSIGNEES
Abbott Laboratories
AccuVein Inc.
Panasonic Corp.
Roche Diagnostics Operations Inc.
CHAPTER 17 GLOBAL POC MARKET
INTERNATIONAL MARKET SIZE
TABLE 71 GLOBAL POC MARKET, BY SEGMENT, THROUGH 2021 ($ MILLIONS)
FIGURE 28 GLOBAL POC MARKET, BY SEGMENT, 2014-2021 ($ MILLIONS)
GLOBAL MARKET SHARES
TABLE 72 GLOBAL POC MARKET SHARE, BY REGION, 2016 (%/$ MILLIONS)
FIGURE 29 NORTH AMERICAN POC MARKET SHARE, BY REGION, 2016 (%)
TABLE 73 NORTH AMERICAN POC MARKET, BY SEGMENT, THROUGH 2021 ($ MILLIONS)
FIGURE 30 EUROPEAN POC MARKET SHARE, BY COUNTRY, 2016 (%)
TABLE 74 EUROPEAN POC MARKET, BY SEGMENT, THROUGH 2021 ($ MILLIONS)
FIGURE 31 ASIAN POC MARKET SHARE, BY COUNTRY, 2016 (%)
TABLE 75 ASIAN POC MARKET, BY SEGMENT, THROUGH 2021 ($ MILLIONS)
TABLE 76 REST OF THE WORLD POC MARKET, BY SEGMENT, THROUGH 2021 ($ MILLIONS)
PRESENCE OF MANUFACTURERS IN THE WORLDWIDE MARKET
TABLE 77 MARKET SHARE OF MAJOR POC MARKET PARTICIPANTS, 2016 (%)
FIGURE 32 MARKET SHARE OF MAJOR POC MARKET PARTICIPANTS, 2016 (%)
CHAPTER 18 PROFILES OF MAJOR MARKET PARTICIPANTS
OVERVIEW OF MARKET PARTICIPANTS
COMPANY PROFILES
ABAXIS INC.
ABBOTT LABORATORIES
ALERE INC.
BECKMAN COULTER INC.
BECTON, DICKINSON AND CO.
CHEMBIO DIAGNOSTICS INC.
CHURCH & DWIGHT CO. INC.
DANAHER CORP.
HEMOCUE AB
INTERNATIONAL TECHNIDYNE CORP.
JOHNSON & JOHNSON
NOVA BIOMEDICAL
ORASURE TECHNOLOGIES
Infectious Disease
Molecular Collectionand Stabilization
Substance Abuse/Insurance Risk Assessment
PHAMATECH INC.
QUIDEL CORP.
RADIOMETER MEDICAL APS
ROCHE
TABLE 78 ROCHE'S RECENT ACQUISITIONS, 2014-2016
SA SCIENTIFIC LTD.
SEKISUI DIAGNOSTICS
SIEMENS MEDICAL SOLUTIONS
POC Products and Solutions:
TRIVIDIA HEALTH INC.
TRINITY BIOTECH PLC
CHAPTER 19 APPENDIX
KEY SOURCES OF INFORMATION
ABAXIS, INC
ABBOTT LABORATORIES
ACON LABORATORIES Inc.
ALERE Inc.
ALFA SCIENTIFIC DESIGNS INC.
ARKRAY INC. KYOTO MIYUKI Bldg. 10F
BECKMAN COULTER Inc.
BECTON, DICKINSON and CO.
BIOMERICA Inc.
BTNX Inc.
CHURCH & DWIGHT CO. Inc.
CLIAWAIVED.COM
COAGUSENSE Inc.
DANAHER CORP.
EKF DIAGNOSTICS COMPANY
FORA CARE Inc.
HEMOCUE AB
INSIGHT PHARMACEUTICALS LLC.
INTERNATIONAL TECHNIDYNE CORP.
JANT PHARMACAL CORP.
JOHNSON & JOHNSON
MERIDIAN BIOSCIENCE Inc.
NOVA BIOMEDICAL
ORASURE TECHNOLOGIES
PHAMATECH Inc.
PRINCETON BIOMEDITECH CORP.
QUEST DIAGNOSTICS
QUIDEL CORP.
RADIOMETER MEDICAL APS
RESPONSE BIOMEDICAL CORP.
ROCHE
SA SCIENTIFIC Ltd.
SEKISUI DIAGNOSTICS
SIEMENS MEDICAL SOLUTIONS
SPECTRAL DIAGNOSTICS
STANBIO LABORATORY
SWISS PRECISION DIAGNOSTICS GMBH
TREVIDIA HEALTH Inc.
TRINITY BIOTECH PLC

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report